Progress toward universal health coverage in Vietnam: Evidence on dispensing trends of diabetes medications from 2015 to 2021
Authors' conclusion
Our data suggested that policies changes were related to significant increase in antidiabetic medication dispenses in Vietnam. The high treatment coverage indicates impressive progress in achieving universal health coverage in Vietnam, meeting the UN Sustainable Development Goal (SDG).
Study context
- Population
- Antidiabetic medicines dispensed in Vietnam, 2015–2021 (General Department of Vietnam Customs; National Health Insurance Program payments)
- Outcome
- Trends in treatment coverage through dispensing of diabetes medications
- Follow-up
- 2015 to 2021
Methodological detailsnational customs and health insurance data, ordinary least squares models
- National customs and health insurance data
- Ordinary least squares models
Main finding
As reported in the abstract
Dispensing trends of antidiabetic drugs
- Total mass/doses of all antidiabetic drugs increased rapidly, based on both databases
- Metformin most frequently prescribed; total mass increased nearly threefold
- Gliclazide (SU) ranked second
Further findings
Association of adults with diabetes (per 1,000 s) with medication mass, multivariate regression
%
- Higher mass of Metformin per one-unit increase in adults with diabetes
- 0.11 (95% CI 0.0005; 0.0076)
- Higher mass of Glimepiride per one-unit increase in adults with diabetes
- 0.13 (95% CI 0.0007; 0.0242)
Original publication
Progress toward universal health coverage in Vietnam: Evidence on dispensing trends of diabetes medications from 2015 to 2021. Diabetes Res Clin Pract. Published 6 May 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →